9AT5

Crystal structure of SARS-CoV-2 3CL protease in complex with a 1-methyl-4,4-difluorocyclohexyl 2-pyrrolidone inhibitor

これはPDB形式変換不可エントリーです。

9AT5 の概要

• エントリーDOI: 10.2210/pdb9at5/pdb
• 分子名称: 3C-like proteinase nsp5, (1R,2S)-2-({N-[({(2S)-1-[(4,4-difluorocyclohexyl)methyl]-5-oxopyrrolidin-2-yl}methoxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid, (1S,2S)-2-({N-[({(2S)-1-[(4,4-difluorocyclohexyl)methyl]-5-oxopyrrolidin-2-yl}methoxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid, ... (5 entities in total)
• 機能のキーワード: protease, severe acute respiratory syndrome coronavirus 2, sars-cov-2 3cl protease inhibitors, covid-19, viral protein, hydrolase-inhibitor complex, hydrolase/inhibitor
• 由来する生物種: Severe acute respiratory syndrome coronavirus 2
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 70536.26

構造登録者

Lovell, S.,Cooper, A.,Battaile, K.P.,Dampalla, C.S.,Groutas, W.C. (登録日: 2024-02-26, 公開日: 2024-07-10)

• 主引用文献: Dampalla, C.S.,Kim, Y.,Zabiegala, A.,Howard, D.J.,Nguyen, H.N.,Madden, T.K.,Thurman, H.A.,Cooper, A.,Liu, L.,Battaile, K.P.,Lovell, S.,Chang, K.O.,Groutas, W.C.; Structure-Guided Design of Potent Coronavirus Inhibitors with a 2-Pyrrolidone Scaffold: Biochemical, Crystallographic, and Virological Studies.; J.Med.Chem., 2024; PubMed: 38953866; DOI: 10.1021/acs.jmedchem.4c00551

実験手法

X-RAY DIFFRACTION (1.45 Å)